Zimmer Biomet Holdings Inc. (ZBH)
NYSE: ZBHHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ZBH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $19.13B
- P/E (TTM)
- 25.53
- Forward P/E
- 11.27
- EPS (TTM)
- $3.96
- Dividend yield
- 0.95% ($0.96)
- Ex-dividend date
- Sep 30, 2026
- 52-week range
- 79.12 – 112.55
- Day range
- 100.82 – 103.84
- Volume / Avg
- 2.96M / 2.15M
- Beta
- —
- Shares outstanding
- 189.25M
52-week range
ZBH stock today
Zimmer Biomet (ZBH) closed at $101.10 on Nov 20, down 0.36% (-$0.37), versus the S&P 500's 3.70% decline. At this level, ZBH sits in the middle of its 52-week range of $79.12 to $112.55: 10.2% below the high, set on Nov 4, 2026 and 27.8% above the low. ZBH is up 12.4% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 9.7%.
At 25.5x trailing earnings, Zimmer Biomet trades above the peer-group median of 22.2x. Its forward P/E of 11.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Zimmer Biomet pays an annual dividend of $0.96 per share, a 0.95% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Zimmer Biomet
Company profileZimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Ivan Tornos
- Headquarters
- Warsaw, IN
- Employees
- 17,000
- Website
- zimmerbiomet.com
Financial highlights
Full financialsIn fiscal 2025, Zimmer Biomet generated $8.23 billion in revenue, up 7.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $705.1 million (-22.0% year over year), for a net margin of 8.6% versus a median of 5.9% in the prior 5 years. Gross margin was 69.7% (down from 71.5%) and operating margin 13.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Growth | +7.20% | +3.85% | +6.55% | +1.65% | +11.42% |
| Net income | $705.10M | $903.80M | $1.02B | $231.40M | $401.60M |
| EPS (diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
Analyst forecast
ForecastConsensus (27 analysts)
buy
Avg. price target
$117.48+16.20%
- Strong buy 2
- Buy 7
- Hold 18
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $1.00 vs $1.89
- Surprise
- -47.09%
Dividends
Dividend history- Annual dividend
- $0.96
- Dividend yield
- 0.95%
- Last payment
- $0.24
- Ex-dividend date
- Sep 30, 2026
ZBH news
All ZBH news- Zimmer Biomet: Fixing Its Own House While Its Rivals Are DistractedSeeking Alpha
- Zimmer Biomet: Solid Sales And Cash Flow Drive A BuySeeking Alpha
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference TranscriptSeeking Alpha
- Zimmer Biomet Eyes Faster Growth in 2027, Targets Earlier Robotics LaunchNasdaq
- Wells Fargo Upgrades Zimmer Biomet Holdings to Overweight from Equal-WeightNasdaqZBH, WSO.B
- Zimmer Biomet upgraded at Wells Fargo on Monogram orthopedic robotSeeking Alpha
- Why is Zimmer Biomet stock climbing today?Investing.com
- Zimmer Biomet Holdings, Inc. Completes Offerings of €500.0 million 4.375% notes due 2033 and $500.0 million 5.850% notes due 2036Nasdaq
Zimmer Biomet peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MASMasco Corporation | 82.60 | -0.23% | $15.92B | vs ZBH |
| STESTERIS plc (Ireland) | 255.76 | +0.39% | $24.84B | vs ZBH |
| SNNSmith & Nephew SNATS Inc. | 29.83 | 0.00% | $12.47B | vs ZBH |
| ALGNAlign Technology Inc. | 155.17 | -2.82% | $10.94B | vs ZBH |
| AITApplied Industrial Technologies Inc. | 274.99 | -4.65% | $10.04B | vs ZBH |
| POOLPool Corporation | 208.23 | -0.70% | $7.44B | vs ZBH |
| MSAMSA Safety Incorporated | 170.03 | -3.52% | $6.55B | vs ZBH |
| DOOBRP Inc. Common Subordinate Voting Shares | 61.90 | -1.56% | $4.40B | vs ZBH |
Indexes, lists and sector
Zimmer Biomet stock FAQ
What is Zimmer Biomet's stock price today?
ZBH last traded at $101.10 as of Nov 20, 4:00 PM EST, down 0.36% on the day. Prices are delayed at least 15 minutes.
Does Zimmer Biomet pay a dividend?
Yes. Zimmer Biomet pays $0.96 per share annually, a 0.95% yield. The most recent dividend of $0.24 had an ex-dividend date of Sep 30, 2026.
What is ZBH's P/E ratio?
ZBH trades at a trailing P/E ratio of 25.53 and a forward P/E of 11.27, compared with a median of 22.2 for its closest peers.
Is Zimmer Biomet in the S&P 500?
Yes. Zimmer Biomet (ZBH) is a constituent of the S&P 500 index.
Who is Zimmer Biomet's CEO?
Mr. Ivan Tornos is the chief executive officer of Zimmer Biomet Holdings Inc., which has about 17,000 employees.
Has ZBH ever split its stock?
Yes. The most recent ZBH stock split was a 103-for-100 split on Mar 1, 2022.
What is the ZBH 52-week high?
The 52-week high for ZBH is $112.55 and the 52-week low is $79.12. The stock is currently 10.2% below its high.